Phospho-BLNK (Tyr96) Antibody

What is BLNK and why is the phosphorylation at Tyr96 significant?

BLNK (B cell linker protein) serves as a central adaptor protein in B lymphocytes that plays critical roles in B cell antigen receptor (BCR) engagement and subsequent B cell activation. BLNK functions by assembling multiple signaling molecules, including phospholipase Cγ2 (PLCγ2), Bruton tyrosine kinase, GRB2, and hematopoietic progenitor kinase 1 (HPK1) .

Phosphorylation at tyrosine 96 (Tyr96) is particularly significant because it occurs during early B cell receptor signaling events. When BCR is cross-linked, it stimulates downstream signaling pathways involved in cell proliferation and apoptosis, including the activation of protein tyrosine kinases such as Syk and Lyn . Syk phosphorylates BLNK at multiple tyrosine residues, creating docking sites for effector proteins that mediate downstream signaling cascades . Phosphorylation at Tyr96 specifically serves as an important marker for active B cell signaling and can be used to monitor B cell activation status in various research contexts.

What applications is Phospho-BLNK (Tyr96) Antibody suitable for?

Phospho-BLNK (Tyr96) Antibody has been validated for multiple research applications:

For flow cytometric applications, the PE-conjugated antibody is recommended at 5 μL per million cells in 100 μL staining volume or 5 μL per 100 μL of whole blood . Researchers should note that optimal dilutions may vary depending on specific experimental conditions, and it is recommended to perform antibody titration to determine the optimal concentration for each application .

What are the species reactivity profiles of different commercially available Phospho-BLNK (Tyr96) Antibodies?

Various commercial antibodies exhibit different species reactivity profiles:

When selecting an antibody for your research, it's crucial to choose one that has been validated for your species of interest. Cross-reactivity information is typically determined through empirical testing by manufacturers and may be updated as new validation data becomes available.

How should I optimize Western Blot protocols for Phospho-BLNK (Tyr96) Antibody?

Optimizing Western Blot protocols for phospho-specific antibodies like Phospho-BLNK (Tyr96) requires careful consideration of sample preparation and detection conditions:

• Sample preparation: Preserve phosphorylation status by including phosphatase inhibitors in lysis buffers. Cell lines such as COLO205 have been successfully used to detect Phospho-BLNK (Tyr96) .

• Antibody dilution: Start with the manufacturer's recommended dilution (typically 1:1000 for Western Blotting) and adjust as needed.

• Blocking conditions: Use BSA-based blocking solutions rather than milk for phospho-specific antibodies, as milk contains phosphoproteins that may interfere with detection.

• Validation controls: Always include phosphopeptide-blocked controls to confirm specificity. COLO205 cell lysates with and without phosphopeptide blocking have been demonstrated as effective controls .

• Detection: The expected molecular weight of phosphorylated BLNK is approximately 68-70 kDa , so ensure your detection system captures this range.

• Stimulation: Consider using B cell receptor cross-linking (anti-IgM) to induce BLNK phosphorylation in B lymphocytes for positive controls .

For troubleshooting purposes, verify the phosphorylation status of upstream kinases such as SYK, which is responsible for BLNK phosphorylation at tyrosine residues .

What controls should be used when working with Phospho-BLNK (Tyr96) Antibody?

Establishing appropriate controls is essential for reliable results when working with phospho-specific antibodies:

• Positive controls:

  • COLO205 cell lysates have been demonstrated as effective positive controls

  • B lymphocytes stimulated with anti-IgM to activate B cell receptor signaling

  • Human peripheral blood lymphocytes treated with pervanadate

• Negative controls:

  • Unstimulated B cells (baseline phosphorylation levels)

  • Samples treated with phosphatase

  • Samples with SYK inhibition (upstream kinase)

• Specificity controls:

  • Phosphopeptide competition assays to demonstrate binding specificity

  • Western blot analysis using both phospho-specific and total BLNK antibodies

  • Immunohistochemistry with paired sections, one blocked with phosphopeptide

• Genetic controls:

  • HPK1-deficient B cells show enhanced BLNK tyrosine phosphorylation and can serve as comparative controls for studies involving regulation of BLNK phosphorylation

Documenting all control results thoroughly is essential for validating experimental findings and ensuring reproducibility.

How can I verify the specificity of Phospho-BLNK (Tyr96) Antibody?

Verifying antibody specificity is crucial for confident data interpretation. For Phospho-BLNK (Tyr96) Antibody, consider these approaches:

• Peptide competition: Pre-incubate the antibody with phosphopeptide corresponding to the Tyr96 region. Loss of signal confirms specificity, as demonstrated in both Western blot and immunohistochemistry applications .

• Phosphatase treatment: Treat half of your sample with lambda phosphatase before immunoblotting. The phospho-specific signal should diminish while total BLNK remains detectable.

• Kinase inhibition: Inhibit upstream kinases (e.g., SYK) that phosphorylate BLNK at Tyr96 and observe reduced signal.

• Mutational analysis: In expression systems, compare detection of wild-type BLNK versus Y96F mutants.

• Knockout/knockdown validation: Compare detection in BLNK-expressing versus BLNK-deficient cells.

Western blot analysis of COLO205 cells using Phospho-BLNK (Y96) Antibody with phosphopeptide blocking provides a clear demonstration of specificity . The signal should disappear when the antibody is pre-incubated with the phosphopeptide, confirming that the antibody specifically recognizes the phosphorylated epitope.

What is the relationship between HPK1, BLNK phosphorylation, and B cell receptor signaling?

HPK1 (Hematopoietic Progenitor Kinase 1) plays a critical role in regulating B cell receptor (BCR) signaling through its interaction with BLNK. Research has revealed a sophisticated regulatory mechanism:

• Negative regulation of BCR signaling: HPK1 functions as a negative regulator of B cell receptor signaling. HPK1-deficient B cells display enhanced tyrosine phosphorylation of BLNK, suggesting that HPK1 normally attenuates this process .

• Dual modification mechanism: HPK1 induces two types of post-translational modifications on BLNK:

  • Phosphorylation at Thr-152, which creates binding sites for 14-3-3 proteins

  • Ubiquitination at Lys-37/38/42

• Downstream consequences: Enhanced BLNK phosphorylation in HPK1-deficient B cells leads to:

  • Increased phosphorylation of PLCγ2, a downstream molecule of BLNK

  • Enhanced calcium flux in response to anti-IgM stimulation

  • Ultimately affecting MAPK activation and other signaling events

• Signaling cascade: The BCR signaling pathway operates as follows:

  • BCR engagement activates Src family kinases (FYN, LYN)

  • SYK is recruited and activated

  • SYK phosphorylates BLNK at multiple tyrosine residues (including Tyr96)

  • Phosphorylated BLNK serves as a scaffold for various signaling molecules

  • HPK1 eventually feeds back to attenuate this pathway

This regulatory circuit provides a mechanism for fine-tuning B cell responses, with HPK1 serving as a brake on excessive B cell activation. This has significant implications for understanding B cell-mediated immune responses and autoimmunity .

How does phosphorylation at different tyrosine residues of BLNK coordinate downstream signaling?

BLNK contains multiple tyrosine residues that become phosphorylated upon B cell receptor stimulation, each contributing distinctly to downstream signaling:

• Tyr96 phosphorylation: While this site is commonly used as a marker for BLNK activation, its specific binding partners and unique contributions need further investigation. The Phospho-BLNK (Tyr96) Antibody allows researchers to specifically track this phosphorylation event .

• Complementary phosphorylation sites: In human BLNK, phosphorylation at tyrosines 84, 178, and 189 (Y84, Y178, and Y189) creates docking sites for specific effector proteins:

  • GRB2 binding

  • Vav binding

  • Nck binding

  • PLCγ2 binding

• Functional consequences: Different phosphorylation patterns likely create distinct "signaling codes" that determine:

  • The magnitude of calcium flux

  • The activation profile of downstream MAPKs

  • The engagement of specific transcription factors

  • Ultimately, cell fate decisions (proliferation, differentiation, or apoptosis)

• Temporal dynamics: Evidence suggests that these phosphorylation events occur with different kinetics and may be differentially regulated by phosphatases and kinases, adding another layer of complexity to BLNK-mediated signaling.

To fully understand BLNK's role in signaling, researchers should consider examining multiple phosphorylation sites simultaneously using phospho-specific antibodies against different residues, combined with mutational studies and downstream readouts.

What methodological approaches can be used to study temporal dynamics of BLNK phosphorylation?

Investigating the temporal dynamics of BLNK phosphorylation requires specialized techniques that capture rapid signaling events:

• Time-course studies: Stimulate B cells with anti-IgM and collect samples at precise time points (0, 30 sec, 1 min, 2 min, 5 min, 10 min, 30 min). Process immediately for phospho-protein analysis using the Phospho-BLNK (Tyr96) Antibody .

• Flow cytometry with phospho-specific antibodies: The PE-conjugated anti-Phospho-BLNK (Tyr96) antibody enables single-cell analysis of phosphorylation kinetics in heterogeneous cell populations . For optimal results:

  • Use 5 μL antibody per million cells in 100 μL staining volume

  • Include proper fixation and permeabilization steps

  • Consider multiparameter analysis to correlate with other signaling events

• Live-cell imaging: Combine fluorescently-tagged BLNK with phospho-binding domains to visualize phosphorylation events in real-time.

• Quantitative phosphoproteomics: Use mass spectrometry-based approaches to quantify multiple phosphorylation sites simultaneously.

• Kinase/phosphatase inhibitor studies: Apply specific inhibitors at various time points to determine the dynamic balance between kinase and phosphatase activities regulating BLNK phosphorylation.

• Single-cell analysis: Techniques like CyTOF (mass cytometry) allow examination of BLNK phosphorylation in relation to multiple other signaling events at the single-cell level, revealing population heterogeneity.

• Biosensors: FRET-based biosensors can be designed to monitor BLNK phosphorylation in live cells with high temporal resolution.

When designing temporal experiments, researchers should carefully coordinate sample collection, fixation timing, and analysis methods to capture the true kinetics of these rapid signaling events.

How can I troubleshoot weak or absent signals when using Phospho-BLNK (Tyr96) Antibody?

When encountering weak or absent signals with Phospho-BLNK (Tyr96) Antibody, consider these methodological solutions:

• Sample preparation issues:

  • Ensure samples are properly stimulated (anti-IgM for B cells)

  • Verify phosphatase inhibitors are fresh and included in all buffers

  • Process samples quickly to prevent dephosphorylation

  • Consider using pervanadate treatment as a positive control

• Antibody-related factors:

  • Verify antibody storage conditions (avoid repeated freeze-thaw cycles)

  • Test a range of dilutions beyond manufacturer recommendations

  • Consider switching to a different clone or vendor if problems persist

  • For flow cytometry, use 5 μL per million cells and optimize staining conditions

• Detection issues:

  • For Western blotting, ensure transfer efficiency of higher molecular weight proteins

  • The expected molecular weight is 68-70 kDa ; confirm you're examining the correct region

  • Use enhanced chemiluminescence substrates for low-abundance phosphoproteins

  • Consider longer exposure times while monitoring background

• Biological variables:

  • Confirm your cell system expresses BLNK (B lymphocytes, some B cell lines)

  • Verify the upstream kinase SYK is active in your system

  • Test COLO205 cells as a positive control system

• Protocol modifications:

  • For IHC/IF applications, test different antigen retrieval methods

  • For Western blotting, try various blocking agents (BSA recommended over milk)

  • Increase antibody incubation time at 4°C overnight

Document all troubleshooting steps methodically to identify the critical variables affecting detection sensitivity in your specific experimental system.

How should I design experiments to study the interplay between BLNK phosphorylation and ubiquitination?

Studying the relationship between BLNK phosphorylation and ubiquitination requires careful experimental design:

• Sequential immunoprecipitation approach:

  • First IP: Use Phospho-BLNK (Tyr96) Antibody at 1:100 dilution to capture phosphorylated BLNK

  • Western blot analysis: Probe with anti-ubiquitin antibodies

  • Reverse approach: IP with anti-ubiquitin followed by Phospho-BLNK (Tyr96) detection

• Time-course analysis:

  • Stimulate B cells with anti-IgM for various durations

  • Split samples for parallel analysis of phosphorylation and ubiquitination

  • Determine if phosphorylation precedes ubiquitination (likely) or vice versa

• Kinase/phosphatase manipulations:

  • Use HPK1 knockout or knockdown systems to assess impact on both modifications

  • Apply selective kinase inhibitors to block phosphorylation events

  • Utilize deubiquitinating enzyme inhibitors to preserve ubiquitination

• Site-directed mutagenesis:

  • Generate BLNK mutants (Y96F to prevent phosphorylation)

  • Create lysine mutants (K37R, K38R, K42R) to prevent ubiquitination

  • Assess how each modification affects the other

• Proteasome inhibition:

  • Treat cells with MG132 or bortezomib to block proteasomal degradation

  • Determine if phosphorylation at Tyr96 leads to protein degradation

• Microscopy approaches:

  • Use fluorescently tagged ubiquitin with Phospho-BLNK (Tyr96) immunostaining

  • Perform proximity ligation assays to visualize co-occurrence of both modifications

Research suggests HPK1 plays a critical role in this process by inducing both Thr-152 phosphorylation (creating 14-3-3 binding sites) and lysine ubiquitination at specific residues (K37/38/42) . This interplay likely represents an important regulatory mechanism for attenuating B cell receptor signaling.

How can Phospho-BLNK (Tyr96) Antibody be used to study B cell dysregulation in disease models?

Phospho-BLNK (Tyr96) Antibody offers valuable opportunities for investigating B cell dysregulation in various disease contexts:

• Autoimmune disease research:

  • Compare BLNK phosphorylation patterns in B cells from autoimmune patients versus healthy controls

  • Flow cytometry with Phospho-BLNK (Tyr96) Antibody can identify aberrantly activated B cell subsets

  • Correlate phosphorylation levels with disease activity in conditions like systemic lupus erythematosus or rheumatoid arthritis

• B cell malignancy studies:

  • Analyze phospho-BLNK levels in lymphoma and leukemia samples using immunohistochemistry (1:100-1:300 dilution)

  • Assess whether phosphorylation status correlates with treatment response or prognosis

  • Use flow cytometry to monitor therapy-induced changes in BLNK phosphorylation

• Immunodeficiency investigations:

  • Evaluate BLNK phosphorylation in primary immunodeficiencies affecting B cell function

  • Combine with functional assays to correlate signaling defects with clinical phenotypes

• Therapeutic intervention assessment:

  • Monitor changes in BLNK phosphorylation during B cell-targeted therapies

  • Use as a pharmacodynamic marker in preclinical and clinical studies

  • Evaluate on-target activity of kinase inhibitors affecting the BCR signaling pathway

• Methodological approaches:

  • Multiparameter flow cytometry combining Phospho-BLNK (Tyr96) detection with lineage and activation markers

  • Tissue microarray analysis of phospho-BLNK expression across disease specimens

  • Single-cell techniques to identify aberrant signaling in rare B cell populations

The ability to specifically detect phosphorylation at Tyr96 provides a precise readout of B cell activation status, making this antibody particularly valuable for identifying dysregulated signaling in pathological conditions where B cells play a central role.

What is the significance of studying HPK1-mediated regulation of BLNK in B cell function?

Understanding HPK1-mediated regulation of BLNK offers significant insights into B cell homeostasis and potential therapeutic targets:

This research area holds promise for developing more targeted approaches to modulate B cell function in autoimmunity, cancer, and inflammatory conditions, moving beyond current B cell-depleting therapies toward more selective immunomodulation.